» Articles » PMID: 39381608

The BRIDGE Project: a Feasibility Randomised Controlled Trial of Brief, Intensive Assessment and Integrated Formulation for Young People (age 14-24) with Features of Borderline Personality Disorder (Protocol)

Overview
Specialty Psychiatry
Date 2024 Oct 9
PMID 39381608
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Borderline personality disorder (BPD) is a severe mental disorder that is characterised by a pervasive pattern of instability of interpersonal relationships, self-image, and mood as well as marked impulsivity. BPD has its peak incidence and prevalence from puberty through to emerging adulthood. BPD is a controversial diagnosis in young people. Commonly, young people with BPD are under-diagnosed, untreated, are not in employment or training and are estranged from their families. Yet, they have complex needs and are at high suicide risk.

Aim: To assess the feasibility of conducting a randomised controlled trial (f-RCT) of a BRIDGE, a brief intervention programme for young people (age 14-24) with BPD symptoms (sub-threshold or threshold) in a community sample from Scotland, UK.

Method: Forty young people (age 14-24) meeting criteria for BPD symptoms, will be randomised in a 1:1 ratio to receive either a) the BRIDGE intervention plus service-as-usual or b) service-as-usual alone. Follow up will be 12 weeks and 24 weeks post-intervention. The study is carried out between 2021 to 2024.

Outcome: The two primary outcomes of the MQ funded, BRIDGE project (f-RCT) are i. recruitment rates and ii. retention rates. The study will present the acceptability and appropriateness of our putative outcome measures for a future definitive randomised controlled trial (d-RCT).

Impact: Young people with BPD benefit from good clinical care and targeted intervention, however are regularly missed or mislabelled. The community based feasibility trial would provide initial evidence of variable needs of young people with complex needs, who maybe missed or excluded from services as they don't "fit" a model/diagnosis. Workable multi-agency service model proposed in the trial would be a major advance in understanding care pathways regardless of trial outcome.

Clinical Trial Registration: ClinicalTrial.gov, identifier NCT05023447.

References
1.
Pinninti N, Madison H, Musser E, Rissmiller D . MINI International Neuropsychiatric Schedule: clinical utility and patient acceptance. Eur Psychiatry. 2003; 18(7):361-4. DOI: 10.1016/j.eurpsy.2003.03.004. View

2.
Gajwani R, Wilson N, Nelson R, Gumley A, Smith M, Minnis H . Recruiting and exploring vulnerabilities among young people at risk, or in the early stages of serious mental illness (borderline personality disorder and first episode psychosis). Front Psychiatry. 2022; 13:943509. PMC: 9386049. DOI: 10.3389/fpsyt.2022.943509. View

3.
Amianto F, Ferrero A, Piero A, Cairo E, Rocca G, Simonelli B . Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study. BMC Psychiatry. 2011; 11:181. PMC: 3260092. DOI: 10.1186/1471-244X-11-181. View

4.
Ryle A . The contribution of cognitive analytic therapy to the treatment of borderline personality disorder. J Pers Disord. 2004; 18(1):3-35. DOI: 10.1521/pedi.18.1.3.32773. View

5.
Singh S, Paul M, Ford T, Kramer T, Weaver T, McLaren S . Process, outcome and experience of transition from child to adult mental healthcare: multiperspective study. Br J Psychiatry. 2010; 197(4):305-12. DOI: 10.1192/bjp.bp.109.075135. View